Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
19.87
0.93 (4.91%)
At close: May 01, 2025, 3:59 PM
19.85
-0.10%
After-hours: May 01, 2025, 04:20 PM EDT
Enliven Therapeutics Revenue
Enliven Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Enliven Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
62
Market Cap
973.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |